02/20/2026

Registration closes 02/20/2026

Precision Oncology with Patient-Derived Organoids (PDOs)

From Patient Tumor to Personalized Treatment—Organoids Power Precision Oncology

  • Mode: Virtual / Online
  • Type: Mentor Based
  • Level:
  • Duration: 3 Days ( 1.5 Hours Per Day)
  • Starts: 20 February 2026
  • Time: 8:00 PM IST

About This Course

Precision oncology requires tools that can capture the complexity of real patient tumors, including heterogeneity, microenvironment interactions, and therapy resistance. Traditional 2D cell cultures often fail to replicate tumor architecture and clinical behavior. Patient-derived organoids, grown directly from tumor tissue, provide physiologically relevant 3D models that preserve genetic and phenotypic characteristics of the original tumor, enabling more accurate drug testing and personalized treatment decisions.

This workshop explores the complete PDO workflow—from tumor sampling and organoid establishment to drug response profiling and therapy strategy development. Participants will understand organoid-based screening approaches, integration with genomics and clinical data, and emerging applications in immuno-oncology and combination therapy design. The workshop emphasizes translational relevance, clinical adoption challenges, and the future of organoid-guided cancer treatment.

Aim

This workshop aims to provide participants with a comprehensive understanding of patient-derived organoids (PDOs) as next-generation platforms for precision oncology and personalized therapy design. It focuses on how tumor samples can be transformed into organoid models for drug screening, biomarker discovery, and treatment response prediction. Participants will learn the translational pipeline from patient tissue to therapy strategy. The program bridges cancer biology, advanced 3D models, and precision medicine innovation.

Workshop Objectives

  • Understand the biology and clinical relevance of patient-derived organoids.
  • Learn the workflow from tumor tissue to organoid culture and expansion.
  • Explore organoid-based drug screening and therapy response prediction.
  • Integrate PDO data with genomics and biomarker strategies.
  • Discuss clinical translation, regulatory challenges, and future directions.

Workshop Structure

Day 1 — PDO Workflow + Smart Study Design

  • How PDOs are used in precision oncology (what works in real research)
  • Assay design: dose range, controls, endpoints, timelines
  • What makes data publishable + reproducible (QC + reporting essentials)
    Output: PDO study design template + control checklist

Day 2 — Hands-on: Build a PDO Drug-Screening Plan

  • Select a cancer type + define the screening goal
  • Create plate map + dose–response plan + controls
  • Decide readouts + pass/fail QC rules
    Output: Complete PDO screening blueprint (ready-to-run)

Day 3 — Hands-on: Therapy Matching + Final Report

  • Use a sample biomarker + response dataset
  • Rank therapies using a scoring sheet (efficacy + confidence)
  • Write a 1-page “tumor board style” recommendation
    Output: Therapy ranking sheet + 1-page precision report

Who Should Enrol?

  • Doctoral Scholars & Researchers: PhD candidates seeking to integrate computational workflows into their molecular research.
  • Postdoctoral Fellows: Early-career scientists aiming to enhance their data-driven publication profile.
  • University Faculty: Professors and HODs interested in modern bioinformatics pedagogy and tool mastery.
  • Industry Scientists: R&D professionals from the Biotechnology and Pharmaceutical sectors transitioning to genomic-driven discovery.
  • Postgraduate Students: Final-year PG students looking for specialized research-grade exposure beyond standard curricula.

Important Dates

Registration Ends

02/20/2026
IST 7:00 PM

Workshop Dates

02/20/2026 – 02/22/2026
IST 8:00 PM

Workshop Outcomes

Participants will be able to:

  • Explain the role of PDOs in precision oncology workflows.
  • Understand organoid establishment, screening, and translational applications.
  • Interpret drug response profiles for therapy strategy design.
  • Recognize challenges in clinical adoption and scalability.
  • Propose future research applications using PDO-based platforms.

Fee Structure

Student Fee

₹1999 | $70

Ph.D. Scholar / Researcher Fee

₹2999 | $80

Academician / Faculty Fee

₹3999 | $95

Industry Professional Fee

₹4999 | $111

What You’ll Gain

  • Live & recorded sessions
  • e-Certificate upon completion
  • Post-workshop query support
  • Hands-on learning experience

Join Our Hall of Fame!

Take your research to the next level with NanoSchool.

Publication Opportunity

Get published in a prestigious open-access journal.

Centre of Excellence

Become part of an elite research community.

Networking & Learning

Connect with global researchers and mentors.

Global Recognition

Worth ₹20,000 / $1,000 in academic value.

Need Help?

We’re here for you!


(+91) 120-4781-217

★★★★★
Cancer Drug Discovery: Creating Cancer Therapies

Undoubtedly, the professor's expertise was evident, and their ability to cover a vast amount of material within the given timeframe was impressive. However, the pace at which the content was presented made it challenging for some attendees, including myself, to fully grasp and absorb the information.

Mario Rigo
★★★★★
Power BI and Advanced SQL Mastery Integration Workshop, CRISPR-Cas Genome Editing: Workflow, Tools and Techniques

Good! Thank you

Silvia Santopolo
★★★★★
Artificial Intelligence for Cancer Drug Delivery

Informative lectures

G Jyothi
★★★★★
Artificial Intelligence for Cancer Drug Delivery

delt with all the topics associated with the subject matter

RAVIKANT SHEKHAR

View All Feedbacks →

Stay Updated


Join our mailing list for exclusive offers and course announcements

Ai Subscriber